SLC11A1 and glioma: Further exploration of the GEPIA database revealed that CD47, CTSZ, and SLC11A1 were highly expressed in various cancers, such as glioma, acute myeloid leukemia-like tumors, and pancreatic cancer (Fig. 8A–C).